-
In patients with multiple cardiovascular risk factors, daily treatment with n-3 fatty acids did not reduce cardiovascular mortality and morbidity.
-
The impression is acute infero-posterior infarction, with possible lateral and right ventricular involvement. In most patients, the right coronary artery (RCA) supplies the right ventricle and posterior and inferior walls of the left ventricle.
-
-
The fda has approved a higher dose of the rivastigmine transdermal system (13.3 mg/24 hours) for the treatment of Alzheimer's disease (AD). Lower-dose patches were previously approved for mild-to-moderate disease. Rivastigamine is a reversible acetylcholinesterase inhibitor. The transdermal system is marketed by Novartis as Exelon.
-
-
I started my emergency medicine practice prior to the widespread availability of pediatric-sized fiberoptic endoscopes. At that time, esophagoscopy using rigid endoscopes was a therapeutic option, but the availability of trained practitioners was limited in many communities.
-
Providers might need to seek other long-acting reversible contraceptive methods other than the new smaller levonorgestrel intrauterine device, Skyla.
-
Enrollment for a 3,200-subject Phase III registration study has been completed for Amphora, a non-hormonal contraceptive gel.
-
Vaccination for human papillomavirus (HPV) rates in US girls ages 13-17 failed to increase between 2011 and 2012.
-
It is critical to address contraception at each interconception visit with women with prior gestational diabetes mellitus (GDM).
